Join the 'Intraocular Hypertension' group to help and get support from people like you.
Intraocular Hypertension News
Aerie Pharmaceuticals Announces U.S. FDA Approval of Rhopressa (netarsudil ophthalmic solution) 0.02% for Patients with Open-Angle Glaucoma or Ocular Hypertension
Posted 19 Dec 2017 by Drugs.com
IRVINE, Calif.--(BUSINESS WIRE)--Dec. 18, 2017-- Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), an ophthalmic pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced that the U.S. Food and Drug Administration (FDA) has ...
Posted 2 Mar 2016 by Drugs.com
WEDNESDAY, March 2, 2016 – A popular "app" that uses your smartphone to check your blood pressure is inaccurate, missing high blood pressure readings in four out of every five patients tested, researchers report. Instant Blood Pressure promises to provide an estimated blood pressure reading if users place their smartphone on the left side of their chest while placing their index finger on the ...
Posted 7 Aug 2015 by Drugs.com
FRIDAY, Aug. 7, 2015 – Pharmacists can play an important role in helping patients control high blood pressure, a new study finds. Researchers followed 625 racially and ethnically diverse Americans with uncontrolled high blood pressure who were seen at 32 medical offices in 15 states. The patients were either cared for by a doctor only, or by a medical team that included a pharmacist. "Clinical ...
Alcon Announces FDA Approval of Simbrinza Suspension, a New Beta Blocker-Free, Fixed-Combination Therapy for Glaucoma Patients
Posted 23 Apr 2013 by Drugs.com
Basel, April 19, 2013 – Alcon, the global leader in eye care and a division of Novartis, announces US FDA approval for Simbrinza Suspension, indicated for the reduction of elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension.4 Elevated IOP is the only modifiable risk factor for glaucoma. Glaucoma is a group of eye diseases that lead to ...
Posted 10 Nov 2010 by Drugs.com
WEDNESDAY, Nov. 10 – A eye condition called corneal arcus may be associated with elevated eye pressure, which in turn is a risk factor for glaucoma, a new study suggests. It also found that corneal arcus – in which a ring of fats accumulates around the cornea – appears to be common in middle-aged and older adults. Corneal arcus may be associated with cardiovascular disease. Researchers ...
Posted 9 Aug 2010 by Drugs.com
MONDAY, Aug. 9 – Patients with glaucoma who have more rapid visual field change than other patients may benefit from a reduction of pressure within the eyeball, new research suggests. In the study, 216 patients with open-angle glaucoma were given standard treatment for controlling intraocular pressure (a targeted reduction of 30 percent or more) and were followed up with re-examination every ...
Related Condition Support Groups
Related Drug Support Groups
latanoprost, Lumigan, Travatan, Xalatan, Combigan, Alphagan, Travatan Z, Cosopt, Azopt, view more... dorzolamide, brimonidine, Zioptan, Alphagan P, Timoptic, Betagan, Trusopt, Rhopressa, travoprost, Simbrinza, brinzolamide, Isopto Carbachol, Timoptic-XE, Rescula, Cosopt PF, Timoptic Ocudose, bimatoprost, Pilopine-HS, tafluprost, carbachol, dipivefrin, dorzolamide / timolol, levobunolol, brimonidine / timolol, Isopto Carpine, Betoptic-S, Piloptic-6, Betimol, Betoptic, metipranolol, Ocupress, unoprostone, Piloptic-3, AK-Beta, Izba, Qoliana, Piloptic-4, Piloptic-2, Pilocar, AK-Pro, Istalol, OptiPranolol, Carbastat, Miostat, Propine, netarsudil, brimonidine / brinzolamide, Betagan C-Cap, Akarpine, Adsorbocarpine, Pilagan with C Cap, Ocu-Carpine, Ocusert, Piloptic-1 / 2, Pilostat, Piloptic-1, Carboptic